184216
Loading viewer...
presentation
Format: PDF presentation
This presentation outlines the topline results from a Phase 1/2 study evaluating the safety and efficacy of Trappsol® Cyclo™ for Niemann-Pick Type C1 Disease.
Loading viewer...
presentation
Format: PDF presentation
This presentation outlines the topline results from a Phase 1/2 study evaluating the safety and efficacy of Trappsol® Cyclo™ for Niemann-Pick Type C1 Disease.
brochure
presentation
Arcadia Biosciences
presentation
Nokian Tyres
presentation
Golar LNG Limited
presentation
Gold Royalty Corporation
